Effective Date :
7/31/2017 12:00:00 AM
Authority :
Sale of Synthetic Drugs Amendment Act of 2016, effective February 18, 2017 (D.C. Law 21-0215; 63 DCR 15708 (December 23, 2016)); the DCRA Infraction Fine Increase Amendment Act of 2017, enacted July 31, 2017 (D.C. Act 22-130; 64 DCR 7652 (August 11, 2017)).
Source :
Final Rulemaking published at 46 DCR 6017 (July 23, 1999); as amended by Final Rulemaking published at 47 DCR 4617 (August 4, 2000); as amended by Final Rulemaking published at 47 DCR 6892 (August 25, 2000); as amended by Final Rulemaking published at 47 DCR 8091 (October 4, 2000); as amended by Final Rulemaking published at 47 DCR 9677 (December 8, 2000); as amended by Final Rulemaking published at 48 DCR 6656 (July 27, 2001); as amended by Final Rulemaking published at 48 DCR 7212 (August 3, 2001); as amended by Final Rulemaking published at 50 DCR 990 (January 31, 2003); as amended by Final Rulemaking published at 50 DCR 1514 (February 14, 2003); as amended by Final Rulemaking published at 51 DCR 7394 (July 30, 2004); as amended by Final Rulemaking published at 52 DCR 4903 (May 27, 2005); as amended by the Fiscal Year 2010 Budget Support Act of 2009, effective March 3, 2010 (D.C. Law 18-111; 57 DCR 181, 210 (January 8, 2010)); as amended by the Sale of Synthetic Drugs Amendment Act of 2016, effective February 18, 2017 (D.C. Law 21-0215; 63 DCR 15708 (December 23, 2016)); as amended by the DCRA Infraction Fine Increase Amendment Act of 2017, enacted July 31, 2017 (D.C. Act 22-130; 64 DCR 7652 (August 11, 2017)).
Editor's Note :